These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9252253)

  • 1. Screening for novel drug effects with a microphysiometer: a potent effect of clofilium unrelated to potassium channel blockade.
    Rabinowitz JD; Rigler P; Carswell-Crumpton C; Beeson C; McConnell HM
    Life Sci; 1997; 61(7):PL87-94. PubMed ID: 9252253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of clofilium block of the human Kv1.5 delayed rectifier potassium channel.
    Malayev AA; Nelson DJ; Philipson LH
    Mol Pharmacol; 1995 Jan; 47(1):198-205. PubMed ID: 7838129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Block of gating currents related to K+ channels as a mechanism of action of clofilium and d-sotalol in isolated guinea-pig ventricular heart cells.
    Malécot CO; Argibay JA
    Br J Pharmacol; 1999 Sep; 128(2):301-12. PubMed ID: 10510439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Block of the inactivating potassium channel by clofilium and hydroxylamine depends on the sequence of the pore region.
    Yool AJ
    Mol Pharmacol; 1994 Nov; 46(5):970-6. PubMed ID: 7969088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo targeting of ERG potassium channels in mice and dogs by a positron-emitting analogue of fluoroclofilium.
    Kim SW; Yang SD; Ahn BJ; Park JH; Lee DS; Gessner G; Heinemann SH; Herdering W; Yu KH
    Exp Mol Med; 2005 Aug; 37(4):269-75. PubMed ID: 16155403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel enhancing effect of clofilium on transient outward-type cloned cardiac K+ channel currents.
    Kobayashi T; Mikala G; Yatani A
    Br J Pharmacol; 1995 Mar; 114(6):1222-6. PubMed ID: 7620712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural determinants of HERG channel block by clofilium and ibutilide.
    Perry M; de Groot MJ; Helliwell R; Leishman D; Tristani-Firouzi M; Sanguinetti MC; Mitcheson J
    Mol Pharmacol; 2004 Aug; 66(2):240-9. PubMed ID: 15266014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K201, a multi-channel blocker, inhibits clofilium-induced torsades de pointes and attenuates an increase in repolarization.
    Hasumi H; Matsuda R; Shimamoto K; Hata Y; Kaneko N
    Eur J Pharmacol; 2007 Jan; 555(1):54-60. PubMed ID: 17112502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of hEAG1 and hERG1 potassium channels by clofilium and its tertiary analogue LY97241.
    Gessner G; Heinemann SH
    Br J Pharmacol; 2003 Jan; 138(1):161-71. PubMed ID: 12522086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of delayed rectifier K+ currents in neuroblastoma x glioma hybrid (NG 108-15) cells by clofilium, a class III antidysrhythmic agent.
    Reeve HL; Peers C
    Br J Pharmacol; 1992 Feb; 105(2):458-62. PubMed ID: 1559135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antiarrhythmic drugs on phospholipid metabolism in Jurkat T cells. The potassium channel blocker, clofilium, specifically increases phosphatidylserine synthesis.
    Aussel C; Pelassy C
    FEBS Lett; 1992 Jun; 304(2-3):281-4. PubMed ID: 1377644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clofilium-induced block of delayed rectifier type K+ current in atrial tumor cells (AT-1 cells).
    Bhattacharyya ML; Sarker S; Mull KP; Debnam Q
    J Mol Cell Cardiol; 1997 Jan; 29(1):301-7. PubMed ID: 9040045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of clofilium on membrane currents associated with Ca channels, NMDA receptor channels and Na+, K+-ATPase in cortical neurons.
    Yang A; Wang XQ; Sun CS; Wei L; Yu SP
    Pharmacology; 2005 Mar; 73(3):162-8. PubMed ID: 15637453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computer Simulations Reveal a Novel Blocking Mode of the hERG Ion Channel by the Antiarrhythmic Agent Clofilium.
    Șterbuleac D; Maniu CL
    Mol Inform; 2018 Jul; 37(6-7):e1700142. PubMed ID: 29465167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]dofetilide binding in SHSY5Y and HEK293 cells expressing a HERG-like K+ channel?
    Finlayson K; Pennington AJ; Kelly JS
    Eur J Pharmacol; 2001 Feb; 412(3):203-12. PubMed ID: 11166283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct mechanisms of block of Kv1.5 channels by tertiary and quaternary amine clofilium compounds.
    Steidl JV; Yool AJ
    Biophys J; 2001 Nov; 81(5):2606-13. PubMed ID: 11606274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifibrillatory effects of clofilium in the rabbit isolated heart.
    Friedrichs GS; Chi L; Green AL; Lucchesi BR
    Br J Pharmacol; 1994 Sep; 113(1):209-15. PubMed ID: 7812612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific block of cloned Herg channels by clofilium and its tertiary analog LY97241.
    Suessbrich H; Schönherr R; Heinemann SH; Lang F; Busch AE
    FEBS Lett; 1997 Sep; 414(2):435-8. PubMed ID: 9315735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potassium channel blockers attenuate hypoxia- and ischemia-induced neuronal death in vitro and in vivo.
    Wei L; Yu SP; Gottron F; Snider BJ; Zipfel GJ; Choi DW
    Stroke; 2003 May; 34(5):1281-6. PubMed ID: 12677023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. hERG channel blockade by externally applied quaternary ammonium derivatives.
    Choi KH; Song C; Shin D; Park S
    Biochim Biophys Acta; 2011 Jun; 1808(6):1560-6. PubMed ID: 21320466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.